Recombinant Human Claudin-3 (CLDN3)-VLPs (Active)

In Stock

Code: CSB-MP005505HU

Rate （5.0）
Review （1）

Size:

20ug100ug1mg

US$558

Quantity:

Express system: Mammalian cell

Species: Homo sapiens (Human)

Tag Info: C-terminal 10xHis-tagged (This tag can be tested only under denaturing conditions)

Send an Inquiry

Start an on-line Chat

Online ordering is currently available for U.S. customers only. For orders outside the U.S., please kindly submit an inquiry or start a chat with us.

Product Details
Related Products
Customer Reviews and Q&A
Target Background

Product Details

Abbreviation

Recombinant Human CLDN3 protein-VLPs (Active)

Endotoxin

Less than 1.0 EU/ug as determined by LAL method.

Activity

Measured by its binding ability in a functional ELISA. Immobilized Human CLDN3 at 10 μg/mL can bind Anti-CLDN3 recombinant antibody (CSB-RA005505MA1HU)， the EC50 is 23.62-34.37 ng/mL.VLPs (CSB-MP3838) is negative control.

Target Names

CLDN3

Uniprot NO.

O15551

Alternative Names

(Clostridium perfringens enterotoxin receptor 2)(CPE-R 2; CPE-receptor 2)(Rat ventral prostate.1 protein homolog)(hRVP1)

Molecular Characterization

Species

Homo sapiens (Human)

Source

Mammalian cell

Expression Region

1-220aa

Target Protein Sequence

MSMGLEITGTALAVLGWLGTIVCCALPMWRVSAFIGSNIITSQNIWEGLWMNCVVQSTGQMQCKVYDSLLALPQDLQAARALIVVAILLAAFGLLVALVGAQCTNCVQDDTAKAKITIVAGVLFLLAALLTLVPVSWSANTIIRDFYNPVVPEAQKREMGAGLYVGWAAAALQLLGGALLCCSCPPREKKYTATKVVYSAPRSTGPGASLGTGYDRKDYV
Note: The complete sequence may include tag sequence, target protein sequence, linker sequence and extra sequence that is translated with the protein sequence for the purpose(s) of secretion, stability, solubility, etc.
If the exact amino acid sequence of this recombinant protein is critical to your application, please explicitly request the full and complete sequence of this protein before ordering.

Mol. Weight

24.7 kDa

Protein Length

Full Length

Tag Info

C-terminal 10xHis-tagged (This tag can be tested only under denaturing conditions)
The tag type will be determined during production process. If you have specified tag type, please tell us and we will develop the specified tag preferentially.

Buffer

Lyophilized from a 0.2 μm filtered PBS, 6% Trehalose, pH 7.4

Storage

Store at -20°C/-81°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.

Lead Time

3-7 business days
Note: All of our proteins are default shipped with normal blue ice packs, if you request to ship with dry ice, please communicate with us in advance and extra fees will be charged.

Notes

Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.

Shelf Life

The shelf life is related to many factors, storage state, storage temperature and the stability of the product itself. Generally, the shelf life of lyophilized form is 6 months at -20°C/-80°C from the date of receipt.

Troubleshooting and FAQs

Protein FAQs

Datasheet & COA

Please contact us to get it.

Images

CSB-MP005505HU is detected by Mouse anti-6*His monoclonal antibody.
Activity
Measured by its binding ability in a functional ELISA. Immobilized Human CLDN3 at 10μg/mL can bind Anti-CLDN3 recombinant antibody (CSB-RA005505MA1HU)， the EC₅₀ is 23.62-34.37 ng/mL.VLPs (CSB-MP3838) is negative control.

Description

Claudin-3 is a critical tight junction component frequently overexpressed in ovarian, breast, and colorectal cancers, making it a high-value target for antibody development and tumor metastasis research. This full-length human CLDN3 (residues 1–220) is presented on virus-like particles produced in mammalian cells, preserving the native four-transmembrane topology essential for conformational epitope recognition. Functional ELISA confirms binding to an anti-CLDN3 recombinant antibody with an EC50 of 23.62–34.37 ng/mL, directly supporting antibody screening, validation campaigns, and integrin-ligand or receptor-ligand binding studies where proper extracellular loop presentation is required. The VLP format maintains membrane protein orientation suitable for cell migration and invasion assay development, and endotoxin levels below 1.0 EU/μg align with standards expected in immune cell trafficking experiments and functional screening workflows.

Customer Reviews and Q&A

■ Customer Reviews

Average Rating:

5.0 - 1 reviews

Submit a Review here

Applications : Enzymatic activity in vitro

Review: Claudin-3 (CLDN3) is a member of the Claudin family of tight junction proteins and plays an important role in forming intercellular tight junctions. The abnormal expression of the CLDN3 protein is closely related to the occurrence and development of various malignant tumors, making it one of the hot targets in current research. The Claudin-3 is a four times transmembrane protein. The full-length recombinant human CLDN3 protein expressed by CUSABIO through its VLP platform has good activity. I used the CSB-MP005505HU product for an ELISA experiment, and the EC50 was measured to be 3.157-5.258 ng/ml, which can be used for my subsequent experimental research, and the results have been promising. The protein is stable with good repeatability, so I will continue to purchase in the future.

By Anonymous

■ Q&A

Could you kindly tell me the purification method of CSB-MP005505HU (Recombinant Human Claudin-3(CLDN3)-VLPs (Active)).
If a virus was used or not and what kind?

The purification method we usually use is Ultracentrifugation + affinity purification.
VLPs (Virus Like Particles) are nanoscale particles formed by the automatic assembly of one or more capsid proteins of enveloped viruses. VLP particles do not contain viral nucleic acid, cannot replicate autonomously, are highly safe, and have an overall structure similar to virus particles.

Target Background

Function(From Uniprot)

Plays a major role in tight junction-specific obliteration of the intercellular space, through calcium-independent cell-adhesion activity.

Gene References into Functions

Claudin3 promoter methylation status (HR: 5.67; 95% CI: 2.2714.17) but not claudin3 expression was an independent predictor of survival. Claudin3 promoter hypermethylation reduces claudin3 expression and independently predicts poor prognosis. PMID:29749528
Immunohistochemical expression levels of cytoplasmic claudins 3 and 7 appear to be novel prognostic factors in triple-negative breast cancer. PMID:29482498
CLDN3 could be further evaluated as a novel biomarker for predicting the prognosis of lung squamous cell carcinoma (SqCC) and as a target for the treatment of lung SqCC in the future. PMID:29511369
We describe a novel workflow, completely covering the analysis of CLDN3 as an exemplary exosome-based biomarker for prostate cancer from in vitro profiling of cancer exosomes over in silico identification and in vitro retesting to clinical validation. PMID:28396511
Data indicate that CDH11, ICAM1 and CLDN3 were overexpressed in tumors when compared to normal esophagus, normal gastric and non-dysplastic Barrett's. PMID:27363029
Study provide first biochemically and clinically validated evidence to support a colorectal cancer-suppressive function of claudin-3 by serving as a conjoint rheostat for regulating Stat-3 and Wnt/beta-catenin-signaling. PMID:28783170
These tumor samples express CD44 protein at low rather than high levels. There is no correlation between CLDN3 gene expression and protein expression in these CPTAC samples; hence, the claudin-low subtype defined by gene expression is not the same group of tumors as that defined by low expression of CLDN3 protein. PMID:28287265
Increased expression of intestinal epithelial claudin-1 with downregulation of claudin-3 has been observed in intestinal inflammatory disorders. PMID:28493289
Data show that the charge of Lys65 in claudin 1 (Cldn1) and Glu158 in claudin 3 (Cldn3), and of Gln57 in claudin 5 (Cldn5) are necessary for tight junction (TJ) strand formation. PMID:28415153
Mislocalization claudin-3 to nucleus in colon cancer and mislocalization claudin-4 to nucleus in adenomas of the colon were detected for the first time. . PMID:28295005
Intracellular zinc has an essential role in the maintenance of the intestinal epithelial tight junction barrier through regulation of occludin proteolysis and claudin-3 transcription. PMID:27151944
permeability barriers and affected cell morphology, proliferation, migration, AKT signaling, and gene expression. When claudins are exogenously expressed, ARPE-19 more closely model native RPE. PMID:27593915
localization of Cldn3, Cldn7 and Cldn10 proteins in the different compartments of murine endometrium up to day 8.5 of pregnancy (dpc) as well as in human endometrium and first trimester decidua PMID:26340953
Cln-3 plays a vital role in TNF-modulated paracellular permeability in submandibular epithelium. PMID:26148935
Further in vitro studies suggested that the isolated MAbs possessed the desired binding properties for the detection or targeting of CLDN3. PMID:25744656
that Claudin-3 expression was restricted to the apical pole of ependymocytes in the subcommissural organ PMID:24974365
The expressions of MARVELD2, CLDN1 and CLDN3 mRNA were significantly lower in cholesteatoma tissue and may be involved in epithelium permeability. PMID:25319490
Univariate analyses indicated that the T stage, lymph node metastasis, the TNM stage, and the expression of claudin-3, beta-catenin, and vimentin were significant predictors for overall survival (OS). PMID:25820701
Data from live-cell imaging suggest at least two different cis-interaction interfaces within CLDN3 homopolymers as well as within CLDN1/CLDN3 heteropolymers. PMID:25849148
our findings demonstrated that CLDN3 is an epigenetically silenced metastasis suppressor gene in Hepatocellular carcinoma PMID:25277196
Study highlights a profound role for the choroid plexus in the pathogenesis of multiple sclerosis, and implies that CLDN3 may be regarded as a crucial and novel determinant of blood-cerebrospinal fluid barrier integrity PMID:24356983
Claudin 3 was expressed in all non-goblet columnar lined oesophagus, Barrett's oesophagus, high grade dysplasia and adenocarcinoma. PMID:24290871
Claudin-3 overexpression increases the malignant potential of colorectal cancer cells. PMID:24069372
folding and assembly of CLDN3 and CLDN5 into the tight junction are controlled by non-conserved residues in the transmembrane 3 and extracellular loop 2 segments PMID:24478310
Our comparative analysis of CLDN3 profile in breast and ovarian cancer clearly indicates organ specificity. PMID:23529315
Snail and Claudin-3 may play important roles in invasion and metastasis in NSCLC PMID:23075682
Claudin-3 expression in uterine luminal epithelium is stimulated by progesterone and suppressed by heparin-binding epidermal growth factor-like growth factor. PMID:23909989
High CLDN3 expression is associated with tumor growth and metastases. PMID:23097631
Dow-regulation of Claudin-3 is associated with the progression of early gastric adenocarcinomas. PMID:22290341
CLDN3 may have a role in ovarian cancer, and its inhibition by short hairpin RNA could be a treatment strategy. PMID:21519794
Analysis of staining intensities of CLDN 1 and 3 is useful as an auxiliary diagnostic and prognostic tool in patients with salivary gland mucoepidermoid carcinoma. PMID:21184237
demonstrate that claudin-3 alters the tight junction meshwork and seals the paracellular pathway against the passage of small ions of either charge and uncharged solutes PMID:20655293
Claudin-3 expression in Epstein-Barr virus-associated nasopharyngeal carcinoma was variable PMID:20204275
Increased expressions of CLDN 2 and 3 suggest structural changes of tight junction in coeliac disease which may be, at least in part, responsible for increased permeability and proliferation observed in coeliac disease. PMID:20143085
Here we show for the first time in both an experimental and clinical setting a strong relation between intestinal tight junction loss and urinary claudin-3 levels PMID:19525861
Airway tight junctions are regulated by claudin interactions that confer the selectivity of the junction. PMID:12909588
up-regulation of DDR1, CLDN3, and epithelial cell adhesion molecule are early events in the development of epithelial ovarian cancer PMID:15240533
in breast tissue, CLDN3 expression is similar in tumours and surrounding normal tissue, as demonstrated by immunohistochemistry and real-time PCR PMID:15743508
claudin-3 phosphorylation by PKA may provide a mechanism for the disruption of tight junctions in ovarian cancer PMID:15905176
The gene expression profile of hepatic stem cells throughout life consists of high levels of expression of claudin-3 (CLDN-3). PMID:16627685
Claudin tight junction proteins in endoscopy biopsy samples showed Barrett's metaplasia contains more claudin-2 and claudin-3 than found in normal esophageal mucosa, but markedly lower claudins 1 and 5, indicating very different tight junction barriers. PMID:17103306
Overexpression of claudin-3 is associated with uterine serous papillary carcinoma PMID:17326053
When compared, small-cell-lung cancers, carcinoid tumors, and adenocarcinomas revealed significant differences re: CLDN3 expression. PMID:17418912
CLDN3 overexpression can be used as a prognostic indicator in ovarian serous carcinomas and it may be a promising target for antibody-based therapy of ovarian carcinomas. PMID:17647191
siRNA-mediated knockdown of Sp1 led to a significant decrease of CLDN3 expression at both the mRNA and protein levels, demonstrating a crucial role for this transcription factor in the regulation of CLDN3. PMID:17986852
Claudin-3 and claudin-7 expression in effusions independently predicts poor survival in ovarian cancer. PMID:18439941
claudins 1 and 3 had a significant effect on overall survival in patients with urothelial carcinoma of the upper urinary tract. PMID:18550469
This is the first study to demonstrate that claudin-3 is involved in the barrier function of gastric epithelial cells and that rebamipide abolishes the H2O2-induced decrease in claudin-3 protein. PMID:18774778
For the first time this study proves the presence of Claudin-1, Claudin-3 and Claudin-5 in ECV304 (obtained from ECACC) cell layers and the inducibility of their expression by glioma-conditioned media. PMID:18817843
Using a panel of four genes (AHRR, p16INK4a, MT1G, and CLDN3) resulted in sensitivity and specificity of 50% and 68%, respectively and may have utility for early detection of esophageal squamous dysplasia and early ESCC. PMID:19137073